Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biogen Pharmachem Industries Ltd has informed BSE that its Board of Directors will meet on Wednesday, 23 July 2025. The main item on the agenda is to approve and take on record the unaudited financial results for the first quarter ended 30 June 2025. The notice also includes a standard 'any other matter with the permission of the board' clause. No financial figures, guidance, or other details have been disclosed at this stage; the filing is purely a regulatory intimation under SEBI LODR Regulation 29.
This is a routine advance notice of the Q1 results announcement and is not material on its own. Shareholders should watch for the actual Q1 results on or after 23 July 2025, which could move the stock depending on the numbers.